Ultrasonic Evaluation of Ocular Tissues

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00279695
Collaborator
Riverside Research Institute (Other)
150
1
173
0.9

Study Details

Study Description

Brief Summary

The objective of this research program is to improve diagnosis and treatment monitoring of ophthalmic disease by improving diagnostic ultrasound techniques. The program explores the use of novel signal and imaging processing techniques towards this end.

Condition or Disease Intervention/Treatment Phase
  • Procedure: high frequency ultrasound examination

Detailed Description

This study involves the diagnosis of several eye diseases, as follows:
Glaucoma:
  1. Morphometry and spectral parameter assays: Clinical correlative studies in primary and secondary glaucoma subgroups: This is a volunteer study to obtain volumetric measurements of age-related changes in the ciliary body and individual ciliary muscle components. The study will provide baseline values for treatment monitoring studies of glaucoma therapeutics. There is minimal risk that the ultrasound procedure may reveal an occult ocular disease process, but the probability is very small. Patients will be informed and assisted in obtaining appropriate care if any abnormality is seen.

  2. Morphometry and spectral parameter assays: Ciliary body drug interactions in patients with initial diagnosis of open angle glaucoma: This study will attempt to document changes in anterior segment functional anatomy related to medical management of glaucoma. We hypothesize that several classes of anti-glaucoma drugs produce permanent modification of ciliary muscle vasculature that is related in turn to loss of drug efficacy over time. Data from COAG patients will be compared with age and sex matched normals. Participation in the study will not effect the ongoing glaucoma therapy of patients.

Accommodation:
  1. Accommodative function in young emmetropes and transitional presbyopes: This is a volunteer study to develop a descriptive model of the human eye's focusing mechanism based on ultrasound morphometric measurements and spectral parameter assays. This study will measure dynamic changes in ciliary body spectral assays (size, CQ2) during calibrated accommodative tasks in volunteers with good amplitude of accommodation and those with accommodative loss do to aging and model 3-D conformal changes in anterior segment structures during accommodation. There is minimal risk that the ultrasound procedure may reveal an occult ocular disease process, but the probability is very small. Patients will be informed and assisted in obtaining appropriate care if any abnormality is seen.

Ocular Tumors

  1. Tumors of the iris and ciliary body: This is an observational study of growth pattern changes in anterior melanoma for the purpose of identifying prognostic variables associated with rapid tumor growth. A percentage of small melanomas are observed for periods of up to several years before demonstrable growth will suggest more aggressive treatment. In the clinical ultrasound practice many patients with these tumors are seen at 3 to 6 month intervals to provide the ophthalmic oncologist with updated tumor volume data. We will examine changes in the ultrasound scattering structure of these tumors over time and their correlation with volume changes. The on-going research data are not released as part of the clinical ultrasound report.

Age-related Macular Degeneration

  1. Posterior examinations: age-related macular degeneration: This study will examine the use of higher frequency (20-30 MHz) ultrasound in the early diagnosis of Age-related macular degeneration. Our hypothesis is that early changes in the choriocapillaries and choroid vascular density and conformation can be detected with high-frequency spectral assays. We will obtain ultrasound scans at frequencies of 20 MHz or more, as well as OCT and fundus photographs. Similar numbers of age-matched control subjects will be examined. Measurements of retinal and choroidal thickness profiles in the peri-macular region will be made. Spectral data will be used for morphologic vascular analysis (size and shape). Statistical comparison will be made using parametric and non-parametric methods between control and AMD groups.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Ultrasonic Evaluation of Ocular Tissues
Study Start Date :
Jan 1, 1996
Anticipated Study Completion Date :
Jun 1, 2010

Arms and Interventions

Arm Intervention/Treatment
1

Subjects with glaucoma and age-matched normals

Procedure: high frequency ultrasound examination
high frequency ultrasound examination of the eye

2

normal volunteers, two age groups, one 18-25 years old, one 50 years and older.

Procedure: high frequency ultrasound examination
high frequency ultrasound examination of the eye

3

subjects with tumors of the iris and ciliary body

Procedure: high frequency ultrasound examination
high frequency ultrasound examination of the eye

4

subjects with age-related macular degeneration and age-matched normals

Procedure: high frequency ultrasound examination
high frequency ultrasound examination of the eye

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Have one of the following eye diseases Glaucoma Ocular Tumors Age-Related Macular Degeneration

    Exclusion Criteria:

    none

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Weill Cornell Medical College New York New York United States 10021

    Sponsors and Collaborators

    • Weill Medical College of Cornell University
    • Riverside Research Institute

    Investigators

    • Principal Investigator: D. Jackson Coleman, MD, Weill Cornell Medical College - New York Presbyterian Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00279695
    Other Study ID Numbers:
    • EB00238
    • 0703009082
    First Posted:
    Jan 19, 2006
    Last Update Posted:
    Jan 20, 2010
    Last Verified:
    Jan 1, 2010

    Study Results

    No Results Posted as of Jan 20, 2010